form8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________

FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  February 19, 2008

AngioDynamics, Inc.
(Exact Name of Registrant as Specified in Charter)


 
Delaware
 
 
000-50761
 
 
11-3146460
 
(State or Other Jurisdiction of Incorporation)
 
(Commission File
Number)
(IRS Employer
Identification No.)

 
 
603 Queensbury Avenue, Queensbury, New York           12804
          (Address of Principal Executive Offices)                           (Zip Code)
 
 
 
(518) 798-1215 
 
(Registrant’s telephone number, including area code)
 
 
 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
 
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
 
 
 
 
 
 
Item 5.02.      Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b)           On February 19, 2008, the Company announced that Robert D. Mitchell, the Company’s Chief Operating Officer, has resigned his position effective February 29, 2008 to become the Chief Executive Officer of Nellix Endovascular, a start-up medical device company.

A copy of the press release issued by the Company on February 19, 2008, announcing the resignation of Mr. Mitchell is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
 
 
 
 
Item 9.01.      Financial Statements and Exhibits.

(d)    Exhibits.
 
 Exhibit No.
  
Description
 
99.1
  
Press Release dated February 19, 2008.
 
 
 
 

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
ANGIODYNAMICS, INC.
 
(Registrant)
   
   
Date: February 19, 2008
By:
/s/ Joseph Gersuk
   
Joseph Gersuk
Chief Financial Officer

 
 
 

 
EXHIBIT INDEX

 Exhibit No.
  
Description
 
99.1
  
Press Release dated February 19, 2008.